跳至主要内容
临床试验/NCT05279326
NCT05279326招募中不适用

Virtual Shared Medical Appointments (SMAs) in Lifestyle Approach for Type 2 Diabetes: Protocol of a Randomized Pragmatic Trial

Universidade do Porto2 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2023年12月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
112
试验地点
2
主要终点
Change in glycaemic management, to be assessed by blood analysis

研究概览

简要总结

This study protocol presents the design of a randomized pragmatic trial. This study aims to determine the effectiveness of virtual shared medical appointments (SMAs) lifestyle approach in improving glycaemic control, compared to usual care in type 2 diabetes (T2D) subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) be 18 years old or older
  • (2) have a diagnosis of T2D with HbA1c ≥ 6.5% within the preceding 6 months
  • (3) have body mass index (BMI) ≥ 25.0 kg/m2 within the preceding 6 months
  • (4) have access to a camera and internet

排除标准

  • unable to attend virtual SMAs for diagnosis of dementia or other cognitive impairment and any behavioral problem, which interferes with group participation and discussion
  • not fluent in Portuguese, and unable to follow conversations, read instructions, and read in Portuguese
  • being pregnant or planning a pregnancy in the next year
  • attending a weight loss and/or physical activity counseling program

结局指标

主要结局

Change in glycaemic management, to be assessed by blood analysis

时间窗: 12 months

Difference between the intervention and control group in the change of serum glycated hemoglobin A1c (HbA1c) concentrations from baseline to the end of follow-up.

次要结局

  • Change in fasting plasma low density lipoprotein (LDL) concentrations, to be assessed by blood analysis(12 months)
  • Change in waist circumference, to be assessed by measuring tape(12 months)
  • Change in the participants' satisfaction, to be assessed by questionnaire(12 months)
  • Change in weight, to be assessed by weight balance(12 months)
  • Change in systolic and diastolic blood pressure, to be assessed by sphygmomanometer(12 months)
  • Change in fasting plasma triglycerides concentrations, to be assessed by blood analysis(12 months)
  • Change in use of medication, to be assessed by electronic health record(12 months)
  • Change in number of individual consultations, to be assessed by electronic health record(12 months)
  • Change in fasting plasma high density lipoprotein (HDL) concentrations, to be assessed by blood analysis(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验